4//SEC Filing
Seizinger Bernd R. 4
Accession 0001104659-23-069421
CIK 0001781983other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 4:34 PM ET
Size
15.5 KB
Accession
0001104659-23-069421
Insider Transaction Report
Form 4
Seizinger Bernd R.
Director
Transactions
- Purchase
Common Stock
2023-06-07$3.68/sh+6,029$22,192→ 26,325 total - Purchase
Common Stock
2023-06-06$3.63/sh+4,068$14,764→ 20,296 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.4984 to $3.75, inclusive. The reporting person undertakes to provide to Aprea Therapeutics, Inc., any security holder of Aprea Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.65 to $3.70, inclusive. The reporting person undertakes to provide to Aprea Therapeutics, Inc., any security holder of Aprea Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
- [F3]Reflects a one-for-20 reverse split, effective as of 5:00 p.m. Eastern Time on February 10, 2023.
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
Related Parties
1- filerCIK 0001789042
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 4:34 PM ET
- Size
- 15.5 KB